Source abstract
Abstract
Abstract Few‐layer graphene (FLG) has garnered much interest owing to applications in hydrogen storage and reinforced nanocomposites. Consequently, these engineered nanomaterials (ENMs) are in high demand, increasing occupational exposure. This investigation seeks to assess the inhalation hazard of industrially relevant FLG engineered with: (i) no surface functional groups (neutral), (ii) amine, and (iii) carboxyl group functionalization. A monoculture of human lung epithelial (16HBE14o‐) cells is exposed to each material for 24‐h, followed by cytotoxicity and genotoxicity evaluation using relative population doubling (RPD) and the cytokinesis‐blocked micronucleus (CBMN) assay, respectively. Neutral‐FLG induces the greatest (two‐fold) significant increase (p < 0.05) in micronuclei, whereas carboxyl‐FLG does not induce significant (p < 0.05) genotoxicity. These findings correlate to significant (p < 0.05) concentration‐dependent increases in interleukin (IL)‐8, depletion of intracellular glutathione (rGSH) and a depletion in mitochondrial ATP production. Uptake of FLG is evaluated by transmission electron microscopy, whereby FLG particles are observed within membrane‐bound vesicles in the form of large agglomerates (>1 µm diameter). The findings of the present study have demonstrated the capability of neutral‐FLG and amine‐FLG to induce genotoxicity in 16HBE14o‐ cells through primary indirect mechanisms, suggesting a possible role for carboxyl groups in scavenging radicals produced via oxidative stress.
Source: crossref · Quality: baseline
Affiliations
Institute of Life Science, Swansea University Medical School Swansea University Singleton Park Swansea Wales SA2 8PP UK
School of Chemical and Process Engineering University of Leeds Leeds LS2 9JT UK
Centre for Cardiovascular Science The University of Edinburgh, Queens Medical Research Institute Edinburgh EH16 4TJ UK
Department of Physics Swansea University Singleton Park Swansea Wales SA2 8PP UK
Perpetuus Carbon Technologies Unit B1, Olympus Court, Millstream Way, Swansea Vale, Llansamlet Swansea SA70AQ UK
Funding
European Social Fund · British Heart Foundation